Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POSITRON: Posaconazole vs Itraconazole in Chronic Pulmonary Aspergillosis
NCT07825259Phase 3Not yet recruiting
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Nov 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 3 trial of posaconazole in chronic pulmonary aspergillosis (CPA), sponsored by Post Graduate Institute of Medical Education and Research. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
posaconazole
03
Conditions
chronic pulmonary aspergillosis (CPA)
Beyond the preview
Go deeper on NCT07825259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07825259.